1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) von Morand, Eric F, Werth, Victoria P, Bender, Andrew, Deshpande, Aditee, Deshmukh, Ankita, Vaidyanathan, Bharat, Vazquez-Mateo, Cristina, Przetak, Melinda, Moreau, Flavie, Khursheed, Mukhy, Roy, Sanjeev, Pearson, David R

Volltext

Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial von McKinnon, John E., Santiaguel, Joel, Murta de Oliveira, Claudia, Yu, Dongzi, Khursheed, Mukhy, Moreau, Flavie, Klopp‐Schulze, Lena, Shaw, Jamie, Roy, Sanjeev, Kao, Amy H., Barbers, Richard, El Ghazal, Roland, Ramachandruni, Srikanth, Zervos, Marcus, De La Rosa, Benjamin, Lima, Marina Andrade, Aguiar, Valeria Cristina, Candida, Caroline, Dal Pizzol, Felipe, Faria Freire, Antonio, Marinho, Ivan Silva, Sato, Victor Augusto Hamamoto, Souza, Tamara Newman Lobato, Germar, Arnold, Raymond, Lawrence O., Santiaguel, Joel M., Bhagat, Pavankumar, Docampo, Zaida Rodriguez, Dörr, Katrin Zaragoza, Englund, Janice, Filho, Marco Antonio Ferraz Nogueira, Garrot, Marcela, Kao, Amy, Labaune, Jean‐Pierre, Knuth, Melanie, Martinez‐Lopez, Noelia, Mondrup, Thomas, Murgasova, Zuzana, Rojik, Christopher, Ruoff, Joerg, Schicker, Simone, Schneider‐Olt, Beate, Thomas, Angela, Thomas, Erik, Yalkinoglu, Özkan, Yeager, Marie

Volltext

LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) von Morand, Eric F, Werth, Victoria P, Bender, Andrew, Deshpande, Aditee, Deshmukh, Ankita, Vaidyanathan, Bharat, Vazquez-mateo, Cristina, Przetak, Melinda, Moreau, Flavie, Mukhy Khursheed, Roy, Sanjeev, Pearson, David R

Volltext